Developments in contraception: a comprehensive review of Desogen® (desogestrel and ethinyl estradiol)

This publication has 116 references indexed in Scilit:

• A comparison of the effects of two monophasic low dose oral contraceptives on the inhibition of ovulation
  Advances in Contraception, 1994
• Clinical Pharmacokinetics of Contraceptive Steroids
  Clinical Pharmacokinetics, 1991
• Metabolic risk factors for coronary heart disease in women: Perspective from the Framingham Study
  American Heart Journal, 1987
• The Reduction in Risk of Ovarian Cancer Associated with Oral-Contraceptive Use
  New England Journal of Medicine, 1987
• The effect of an oral contraceptive containing ethinylestradiol and desogestrel on hair growth and hormonal parameters of hirsute women
  International Journal of Gynecology & Obstetrics, 1986
• Oral-Contraceptive Use and the Risk of Breast Cancer
  New England Journal of Medicine, 1986
• Central and Peripheral Effects of Desogestrel 15–60 μg Daily for 21 Days in Healthy Female Volunteers
  Acta Obstetricia et Gynecologica Scandinavica, 1982
• On the use of Plasma Proteins as Indicators of the Metabolic Effects of Combined Oral Contraceptives
  Published by Wiley ,1982
• Ethinylestradiol and a New Progestogen (Desogestrel) in a Low-Dose Combination: Effects on Pituitary-Gonadal Function, Serum Sex-Hormone Binding Globulin Capacity, Endometrium and Cervical Mucus
  Published by Wiley ,1982
• Oral contraceptives and cardiovascular disease
  American Heart Journal, 1981